Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Roivant Sciences Ltd. Director's Dealing 2024

Sep 27, 2024

30587_dirs_2024-09-26_ec80ca72-b876-41d6-9fb6-8a06bf638650.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2024-09-24

Reporting Person: MANCHESTER KEITH S (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-09-24 Common Shares S 368052 $11.625 Disposed 1412126 Direct
2024-09-25 Common Shares S 134948 $11.7653 Disposed 1277178 Direct